NEFL and Alzheimer disease: Thus, for example, cerebrospinal fluid (CSF) and blood levels of the neurofilament light chain (NfL) have been used as a sensitive biomarker for neuroaxonal damage that can monitor neurodegeneration and progression of Alzheimer’s disease dementia, albeit not specific (Norgren et al., 2003; Gaiottino et al., 2013).